A Study of LY2623091 in Male and Females With Chronic Kidney Disease

NCT01427972 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: LY2623091
DRUG: Eplerenone

Sponsor

Eli Lilly and Company